Taiyen Biotech Co Ltd (1737) — Cash Flow Reinvestment Rate
Taiyen Biotech Co Ltd (1737) has a Cash Flow Reinvestment Rate of 0.26x as of March 2026, reinvesting NT$44.39 Million (capex NT$44.39 Million ) from operating cash flow of NT$173.44 Million. Check 1737 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Taiyen Biotech Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Taiyen Biotech Co Ltd across 23 annual periods. Explore Taiyen Biotech Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Taiyen Biotech Co Ltd. For live market cap and broader valuation context, see Taiyen Biotech Co Ltd (1737) total market value.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.69x | NT$328.17 Million | NT$473.77 Million | NT$300.16 Million | ▲ +42.1% |
| 2024 | 0.49x | NT$321.68 Million | NT$660.12 Million | NT$307.61 Million | ▼ -67.6% |
| 2023 | 1.51x | NT$684.43 Million | NT$454.54 Million | NT$345.13 Million | ▲ +252.8% |
| 2022 | 0.43x | NT$247.87 Million | NT$580.69 Million | NT$246.60 Million | ▼ -39.0% |
| 2021 | 0.70x | NT$419.61 Million | NT$600.08 Million | NT$390.81 Million | ▼ -11.8% |
| 2020 | 0.79x | NT$269.06 Million | NT$339.36 Million | NT$267.89 Million | ▼ -36.3% |
| 2019 | 1.24x | NT$411.65 Million | NT$330.81 Million | NT$284.25 Million | ▲ +63.1% |
| 2018 | 0.76x | NT$343.19 Million | NT$449.83 Million | NT$298.49 Million | ▼ -16.0% |
| 2017 | 0.91x | NT$551.88 Million | NT$607.87 Million | NT$369.68 Million | ▲ +6.9% |
| 2016 | 0.85x | NT$482.65 Million | NT$568.06 Million | NT$190.30 Million | ▲ +130.0% |
| 2015 | 0.37x | NT$141.84 Million | NT$383.93 Million | NT$106.57 Million | ▼ -54.5% |
| 2014 | 0.81x | NT$300.97 Million | NT$371.06 Million | NT$148.81 Million | ▼ -34.1% |
| 2013 | 1.23x | NT$250.23 Million | NT$203.21 Million | NT$93.53 Million | ▲ +73.8% |
| 2012 | 0.71x | NT$109.40 Million | NT$154.46 Million | NT$109.40 Million | ▲ +126.8% |
| 2011 | 0.31x | NT$76.85 Million | NT$246.09 Million | NT$76.85 Million | ▼ -25.5% |
| 2010 | 0.42x | NT$126.08 Million | NT$300.89 Million | NT$126.08 Million | ▲ +30.8% |
| 2009 | 0.32x | NT$114.67 Million | NT$358.02 Million | NT$114.67 Million | ▼ -30.4% |
| 2008 | 0.46x | NT$192.08 Million | NT$417.51 Million | NT$192.08 Million | ▲ +86.2% |
| 2007 | 0.25x | NT$79.70 Million | NT$322.49 Million | NT$79.70 Million | ▼ -22.9% |
| 2006 | 0.32x | NT$148.45 Million | NT$462.88 Million | NT$148.45 Million | ▲ +43.0% |
| 2005 | 0.22x | NT$129.19 Million | NT$575.91 Million | NT$129.19 Million | ▲ +229.6% |
| 2004 | 0.07x | NT$192.93 Million | NT$2.84 Billion | NT$192.93 Million | ▲ +146.5% |
| 2003 | 0.03x | NT$94.39 Million | NT$3.42 Billion | NT$94.39 Million | — |